NEW APPROACH IN URTICARIA TREATMENT
Vestnik Dermatologii i Venerologii, 2017 The article presents the European Guidelines for the Diagnostics and Management of Urticaria (revised in 2013) and new data on the physiopathology of urticaria related to the role of the platelet-activating factor (PAF) activating mast cells, attracting ...
A. V. Samtsov
doaj +1 more source
Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. [PDF]
, 2006 Psoralen plus UVA (PUVA) is used as a very effective treatment modality for various diseases, including psoriasis and cutaneous T-cell lymphoma. PUVA-induced immune suppression and/or apoptosis are thought to be responsible for the therapeutic action ...
Ananthaswamy, Honnavara N +8 more
core +2 more sources
Journal of Immunology, 1982 Rat adherent macrophages (M phi) isolated from 2.5 x 10(6) peritoneal cells release 5.7 +/- 1.3 ng/ml platelet-activating factor (PAF-acether: 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) when stimulated by zymosan (Z).
J. Mencia-Huerta +3 more
semanticscholar +1 more source
Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion. [PDF]
, 1990 TW Evans +5 more
openalex +2 more sources
Journal of Lipid Research, 1987 Two platelet-activating factor (PAF) analogs containing a methyl group at C2 of the glycerol moiety were synthesized, and some of their biochemical properties were investigated.
R Bittman +4 more
doaj +1 more source
Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration. [PDF]
, 2010 BACKGROUND: An early event in the neuropathology of prion and Alzheimer's diseases is the loss of synapses and a corresponding reduction in the level of synaptophysin, a pre-synaptic membrane protein essential for neurotransmission.
Bate, Clive +2 more
core +1 more source
Receptor mechanisms of PAF mediated lymphatic constriction in the canine forelimb
Mediators of Inflammation, 1992 Platelet activating factor (PAF) is a potent inflammatory lipid. In this study we assessed the ability of PAF to impact lymphatic vessel function by altering prenodal lymphatic resistance.
D. E. Dobbins
doaj +1 more source
Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome. [PDF]
, 2014 RATIONALE: Acute respiratory distress syndrome (ARDS) affects over 200000 people annually in the USA. Despite causing severe, and often refractory, hypoxaemia, the high mortality and long-term morbidity of ARDS results mainly from extra-pulmonary organ ...
Balan, KK +8 more
core +4 more sources
Correlation of Lipopolysaccharide Endotoxin Level in Cotton Dust with the Increase of TNFα Level and the Decline of Lung Function in Cotton Spinning Factory Workers [PDF]
, 2014 Lipopolysaccharide (LPS) endotoxin contained in cotton dust may cause airway inflammation and decline of lung function when inhaled, which eventually leads to respiratory symptoms.
Indahwati, L. (Leli) +2 more
core +2 more sources
Platelet-Activating Factor (PAF) in Internal Jugular Venous Blood of Migraine without aura Patients Assessed during Migraine Attacks [PDF]
, 2004 Paola Sarchielli +8 more
openalex +1 more source